Placebo-free designs for evaluating new mental health treatments: The use of adaptive treatment strategies

Statistics in Medicine

Volumn 23, Issue 21, 2004, Pages 3249-3262

  Dawson, Ree ^a   Lavori, Philip W ^b,c  

^a FRONTIER SCIENCE AND TECHNOLOGY RESEARCH FOUNDATION   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adaptive treatment strategies; Mental health treatment designs; Placebo control; Sample size requirements

Indexed keywords

NEW DRUG; PLACEBO;

ARTICLE; CLINICAL PRACTICE; DRUG APPROVAL; DRUG EFFICACY; DRUG MARKETING; DRUG SCREENING; HUMAN; MEDICAL DECISION MAKING; MENTAL DISEASE; OUTCOMES RESEARCH; PSYCHOPHARMACOLOGY; RANDOMIZATION; STANDARD; STATISTICAL ANALYSIS;

ANTIPSYCHOTIC AGENTS; DECISION MAKING; HUMANS; MENTAL DISORDERS; PLACEBOS; RANDOMIZED CONTROLLED TRIALS; RESEARCH DESIGN; STATISTICS;

EID: 7744234104     PISSN: 02776715     EISSN: None     Source Type: Journal    
DOI: 10.1002/sim.1920     Document Type: Article

References (23)

1. Lavori PW. Placebo control groups in randomized treatment trials: a statistician's perspective. Biological Psychiatry 2000; 47:717-723.
2. Leber PD. Hazards of inference: the active control investigation. Epilepsia 1989; 30:557-563.
3. Temple R, Ellenberg SS. Placebo-controlled trials and active-control trials in the evaluation of new treatments. Part I: ethical and scientific issues. Annals of Internal Medicine 2000; 133:456-464.
4. Fins JJ, Milller FG. The call of the sirens. Navigating the ethics of medication-free research in schizophrenia. Archives of General Psychiatry 1997; 54:415-416.
5. Ellenberg SS, Temple R. Placebo-controlled trials and active-control trials in the evaluation of new treatments. Part II: practical issues and specific cases. Annals of Internal Medicine 2000; 133:464-470.
6. Lavori PW, Wagner TH, Feussner JR. Ethics and economics in placebo-controlled trials of new drugs for moods disorders. The Economics of Neuroscience 2000; 2:44-48.
7. D'Agostino Sr RB, Massaro JM, Sullivan LM. Non-inferiority trials: design concepts and issues - the encounters of academic consultants in statistics. Statistics in Medicine 2003; 22 169-186.
8. Lavori PW, Dawson R. Developing and comparing treatment strategies: an annotated portfolio of designs. Psychopharmacology Bulletin 1998; 34:13-18.
9. Lavori PW, Dawson R, Rush AJ. Flexible treatment strategies in chronic disease: clinical research implications. Biological Psychology 2000; 48:605-614.
10. Murphy SA, Van der Laan MJ, Robins JM & CPPRG. Marginal mean models for dynamic regimes. Journal of American Statistical Association 2001; 96:1410-1423.
11. Thall PF, Millikan RE, Sung H-G. Evaluating multiple treatment courses in clinical trials. Statistics in Medicine 2000; 19:1011-1028.
12. Dawson R, Lavori PW. Comparison of designs for adaptive treatment strategies: baseline vs. adaptive randomization. Journal of Statistical Planning and Inference 2003; 117:365-385.
13. Cohen J. Approximage power and sample size determination for common one-sample and two-sample hypothesis tests. Educational and Psychological Measurement 1970; 30:811-831.
14. Wellek S. On a reasonable disaggregate criterion of population bioequivalence admitting of resampling-free procedures. Statistics in Medicine 2000; 19:2755-2768.
15. Fleiss JL. Statistical Methods for Rates and Proportions (2nd edn). Wiley: New York, 1981.
16. Fleming TR, Demets DL. Monitoring of clinical trials: issues and recommendations. Controlled Clinical Trials 1993; 14 183-197.
17. Post RM, Weiss SRB, Ketter TA, Denicoff KD, George MS, Frye M, Leverich GR. Kindling: implications for the etiology and treatment of mood disorders. In Current Review of Mood Disorders, John Rush A (ed.). Current Medicine: Philadelphia, PA, 1997.
18. Linszen D, Lenoir M, de Haan L, Dingemans P, Gersons B. Early intervention, untreated psychosis, and the course of early schizophrenia. British Journal of Psychiatry 1998; 172:84-89.
19. Swann AC, Bowden CL, Calabrese JR, Dilsaver SC, Morris DD. Differential effect of number of previous episodes of affective disorder on response to lithium or divalproex in acute mania. American Journal of Psychiatry 1999; 156:1264-1266.
20. Drake RJ, Haley CJ, Akhtar S, Lewis SW. Causes and consequences of duration of untreated psychosis in schizophrenia. British Journal of Psychiatry 2000; 177:511-515.
21. Kendler KS, Thornton LM, Gardner CO. Stressful life events and previous episodes in the etiology of major depression in women: an evaluation of the 'kindling' hypothesis. American Journal of Psychiatry 2000; 157:1243-1251.
22. Lavori PW, Keller M, Scheftner W, Fawcett J, Mueller TI, William C. Recurrence after recovery in unipolar MDD: an observational follow-up study of clinical predictors and somatic treatment as a mediating factor. International Journal of Methods in Psychiatric Research 1994; 4:211-229.
23. Hung HMJ, Wang S-J, Tsong Y, Lawrence J, O'Neil RT. Some fundamental issues with non-inferiority testing in active controlled trials. Statistics in Medicine 2003; 22:213-225.